Hosted by the award-winning editorial staff of Ophthalmology Times®, EyePod podcasts feature the latest updates and resources most relevant to professionals across the eyecare industry. Two sponsored EyePod episodes are released each month exclusively on the Ophthalmology Times® website
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics
June 28th 2024In this PER On Air Ophthalmology Times podcast, a team of experts provides insights into the diagnosis and management of patients with NK (including assessing their underlying cause of NK), with a look at the range of treatments available for patients with advanced stages of NK.
Novel Therapies for Neovascular Retinal Disease - Expert Analysis of New Key Data
June 28th 2024In this PER On Air Ophthalmology Times Podcast, a panel of experts takes a closer look at newer-generation anti-VEGF agents for the treatment of nAMD and DME, sharing insights into clinical trial and real-world data, patient education, and other important considerations for treatment.
Innovation Series: A stem cell patch for treating advanced dry AMD
June 27th 2024In this Ophthalmology Times EyePod podcast, Mandeep S. Singh, MD, PhD, speaks with Mark S. Humayun, MD, PhD, about the progress made by a team of USC researchers on a novel stem cell patch for treating advanced dry age-related macular degeneration.
(EyePod) From idea to impact: Navigating ophthalmic innovation
March 29th 2024Explore cutting-edge ophthalmology innovations in this new series on the Ophthalmology Times EyePod podcast. Throughout this series, we'll hear insights from various stakeholders in clinical practice, academia, and industry. In this episode, host Ehsan Sadri, MD, engages in a conversation with Jeffry Weinhuff, managing partner at Visionary Ventures, exploring trends and offering advice for individuals driven by an entrepreneurial mindset.
EyePod: Integrating cutting-edge pipeline devices for enhanced cataract surgery
December 19th 2023In this podcast, Neda Shamie, MD, and Peter J. McDonnell, MD, discuss real-world experiences, patient choices, and the nuances of integrating femtosecond laser-assisted cataract surgery into practice, offering insights into the latest developments in ophthalmology.
EyePod: Navigating the premium lens landscape from pipeline to practice
December 13th 2023In this episode, Neda Shamie, MD, and Peter J. McDonnell, MD, discuss the benefits and challenges of implementing the many options from the premium lens pipeline into practice, emphasizing the importance of customization based on patients' lifestyles and expectations, while also addressing concerns and sharing their positive experiences with the evolving technology in the field.
Diabetic Macular Edema – Considering Pathogenesis in Treatment Selection
October 18th 2023This special edition of the Ophthalmology Times® EyePod, recorded in conjunction with Physicians’ Education Resource, examines how key therapies for treating diabetic macular edema—anti-VEGF agents and corticosteroids—address the underlying pathophysiology of the condition to effectively and safely treat it. In this podcast, J. Fernando Arevalo, MD, PhD, FACS, FASRS; Peter Kaiser, MD; and Nathan Steinle, MD, share their insights to help clinicians optimize care for their patients with this common diabetes-related eye disease.
nAMD and DME Management: Figuring Out the Timing
October 17th 2023This special edition of the Ophthalmology Times® EyePod recorded in conjunction with Physicians’ Education Resource features an international panel of ophthalmologists, including Arshad M. Khanani, MD, MA, FASRS; Carl J. Danzig, MD, FASRS; and Anat Loewenstein, MD, MHA, who will discuss unmet needs in the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) — and opportunities for extended treatment intervals that newer agents might provide. This program is designed to help clinicians better appreciate limitations of traditional anti-VEGF agents and optimize the growing toolkit of available therapies.
EyePod: Transforming the MIGS pipeline into clinical reality
September 26th 2023Peter J. McDonnell, MD, and Neda Shamie, MD, discuss the transformative impact of minimally invasive glaucoma surgery (MIGS) on glaucoma care and its integration with cataract surgery, sharing insights and practical tips for ophthalmologists.
Podcast: Modern approaches for the optimal treatment of dry eye disease (Part 4)
September 13th 2023Bill B. Trattler, MD, Crystal Brimer, OD, Cynthia Matossian, MD, FACS, and Kelly K. Nichols, OD, MPH, PhD, discuss dry eye disease and the various approaches clinicians can take to treat the disease in part 4 of the Viewpoints Podcast.
Podcast: Modern approaches for the optimal treatment of dry eye disease (Part 3)
September 13th 2023Bill B. Trattler, MD, Crystal Brimer, OD, Cynthia Matossian, MD, FACS, and Kelly K. Nichols, OD, MPH, PhD, discuss dry eye disease and the various approaches clinicians can take to treat the disease in part 3 of the Viewpoints Podcast.
Podcast: Modern approaches for the optimal treatment of dry eye disease (Part 2)
September 13th 2023Bill B. Trattler, MD, Crystal Brimer, OD, Cynthia Matossian, MD, FACS, and Kelly K. Nichols, OD, MPH, PhD, discuss dry eye disease and the various approaches clinicians can take to treat the disease in the second part of the Viewpoints Podcast.
Podcast: Modern approaches for the optimal treatment of dry eye disease (Part 1)
September 13th 2023In this podcast, Bill B. Trattler, MD, Crystal Brimer, OD, Cynthia Matossian, MD, FACS, and Kelly K. Nichols, OD, MPH, PhD, discuss dry eye disease and the various approaches clinicians can take to treat the disease.
(Podcast) Confronting Demodex blepharitis: From rude awakening to FDA-approved solution
August 30th 2023In this podcast episode, Ophthalmology Times' co-chief medical editors Peter J. McDonnell, MD, and Neda Shamie, MD, delve into the clinical nuances of Demodex blepharitis. Through personal anecdotes, they stress its underrecognized gravity and discuss diagnostic cues like collarettes. The experts share their enthusiasm for improved treatments, echoing the transformative impact seen in dry eye care.